Emerging Infectious Disease ISSN: 1080-6059
Volume 18, Number 9—September 2012
CME ACTIVITY
Control of Fluoroquinolone Resistance through Successful Regulation, Australia
Figure 1

Figure 1. . . Data from Drug Utilization Sub-Committee Drug Utilization Database on Pharmaceutical Benefits Scheme and the Repatriation Pharmaceutical Benefits Scheme (RPBS) on subsidized medicines and estimates of non-subsidized medicines. RPBS data were calculated from continuous data on all prescriptions dispensed from a validated sample of community-based pharmacies. In-patient hospital prescribing is not included. Usage rate calculated on the basis of medication use of 1,000 persons per day. DDD, defined daily dose.
New Flu Virus in Pigs Exhibited at Fairs in Ohio
Length: 11:58





